Cytokine profile of cervical cancer cells

被引:73
作者
Hazelbag, S [1 ]
Fleuren, GJ
Baelde, JJ
Schuuring, E
Kenter, GG
Gorter, A
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Obstet & Gynecol, NL-2300 RC Leiden, Netherlands
关键词
cervix cancer cytokines;
D O I
10.1006/gyno.2001.6378
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. In patients with cervical carcinoma, the presence of cytokines produced by T(H)2 cells, and the presence of an eosinophilic inflammatory infiltrate, has been associated with a less effective immune response and tumor progression. In the present study, we have investigated the cytokine profile of cervical carcinoma cells. In addition, we have measured whether differences in cytokine profiles between normal and malignant cervical epithelial cells are present. Methods. For this purpose we have determined the mRNA expression patterns of 20 relevant cytokines by RT-PCR and Southern blotting in 3 normal primary cervical epithelial cell cultures (NPE) and 10 cervical cancer cell lines (CCCL). Results. TGF-beta (1), IL-4, IL-12p35, and IL-15 were produced by all CCCL and NPE. TNF-alpha, IL-10, IL-5, and RANTES were present in most NPE, but not in any of the CCCL. MCP-1 was expressed in all CCCL but in only one NPE. The presence of the anti-inflammatory cytokine TGF-beta (1) in cervical carcinomas was confirmed by RNA in situ hybridization on tissue sections of carcinomas from which the CCCL originated. Conclusions. Our results suggest that cervical carcinoma cells produce immunomodulatory cytokines and that cytokine expression patterns change after malignant transformation. The implications of locally produced cytokines by cervical cancer cells are further discussed. (C) 2001 Academic Press.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 58 条
[1]  
Al-Saleh W, 1998, J PATHOL, V184, P283, DOI 10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO
[2]  
2-K
[3]  
ALEXANDROW MG, 1995, CANCER RES, V55, P1452
[4]  
[Anonymous], IARC MON EV CARC RIS
[5]  
[Anonymous], 1992, PAPILLOMAVIRUS REP
[6]  
Austyn J M, 1998, Curr Opin Hematol, V5, P3, DOI 10.1097/00062752-199801000-00002
[7]   Human dermal fibroblasts express eotaxin: Molecular cloning, mRNA expression, and identification of eotaxin sequence variants [J].
Bartels, J ;
Schluter, C ;
Richter, E ;
Noso, N ;
Kulke, R ;
Christophers, E ;
Schroder, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :1045-1051
[8]  
BOSTROM SG, 1981, CANCER, V47, P2887, DOI 10.1002/1097-0142(19810615)47:12<2887::AID-CNCR2820471223>3.0.CO
[9]  
2-3
[10]  
Chen TP, 1999, INT J CANCER, V82, P43